Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
33.3(c) 33.5(c) 34.3(c) 34.19(c) 34.28(c) Last
1 196 747 1 689 752 1 284 524 651 209 767 706 Volume
+0.82% +0.60% +2.39% -0.32% +0.26% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
02/18Earnings Release
Surperformance© rating of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More about the company
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 399 M
EBIT 2014 16,6 M
Net income 2014 -
Debt 2014 479 M
Yield 2014 -
Sales 2015 484 M
EBIT 2015 105 M
Net income 2015 -
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 5,58x
EV / Sales 2015 4,37x
Capitalization 1 749 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
1d ago AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
1d ago AUXILIUM PHARMACEUTICALS : "Method of Treating Or Reducing EFP" in Patent Applic..
11/20 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
11/20 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
11/20 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
11/19 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
11/19 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Other Events, Financial Sta..
11/19 AUXILIUM PHARMACEUTICALS : Antares Pharma Appoints James E. Fickenscher, Senior ..
11/19 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
11/19 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
11/18 AUXILIUM PHARMACEUTICALS : Creation of a Direct Financial Obligation or an Oblig..
11/12 AUXILIUM PHARMACEUTICALS : to Present XIAFLEX and STENDRA Data at SMSNA Scientif..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF